FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees
PMA: P190009
·
Supplement: S004
·
Decision Dec 21, 2023
Classifications
1
FEI Numbers
5
Registration Numbers
5
Basic Information
- Device Name
- Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees
- Trade Name
- OPRA Implant System
- PMA Number
- P190009
- Supplement Number
- S004
- Device Class
- FDA Class 3
- Product Code
- PJY
- Generic Name
- Osseoanchored prostheses for the rehabilitation of transfemoral amputees
- Medical Specialty
- Unknown
- Advisory Committee
- Orthopedic
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- December 21, 2023
- Date Received
- September 25, 2023
- Supplement Type
- Real-Time Process
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
Your supplement requested approval for material changes from Oilon to PEEK for the bending and torque punch components of Axor II, OPRA Implant System.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| PJY | Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees | FDA class 3 | Unknown |